Integrating Accompanying Patients into Clinical Oncology Teams: Limiting and Facilitating Factors

Author:

Pomey Marie-Pascale1,Paquette Jesseca1,Nelea Monica Iliescu1,Vialaron Cécile1,Mourad Rim1,Bouchard Karine2,Normandin Louise1,Côté Marie-Andrée1,Desforges Mado1,Pomey-Carpentier Pénélope1,Fortin Israël3,Ganache Isabelle4,Régis Catherine5,Rosberger Zeev6,Charpentier Danielle7,Vachon Marie-France7,Bélanger Lynda2,Dorval Michel8,Ghadiri Djahanchah P.9,Lavoie-Tremblay Mélanie10,Boivin Antoine1,Pelletier Jean-François11,Fernandez Nicolas10,Danino Alain M.7,de Guise Michèle4

Affiliation:

1. University of Montreal Hospital Centre

2. Centre Hospitalier Universitaire- CHU de Québec-Université Laval

3. Centre Intégré Universitaire de santé et services sociaux de l’Est-de-l’Île-de Montréal, Hôpital de Maisonneuve-Rosemont

4. Institut national d’excellence en santé et services sociaux (INESSS)

5. Université de Montréal – Faculté de Droit

6. Jewish General Hospital

7. Centre Hospitalier Universitaire de Montréal (CHUM)

8. Université Laval – Faculté de pharmacie

9. HEC Montréal

10. Université de Montréal

11. Centre intégré de santé et de services sociaux de la Montérégie-Ouest

Abstract

Abstract Objectives Since 2018, four establishments in Quebec have been instrumental in implementing the PAROLE-Onco program, which introduced accompanying patients (APs) in healthcare teams to improve cancer patients’ experience. APs are patient advisors who have acquired specific experiential knowledge related to living with cancer, using services, and interacting with healthcare professionals. They are therefore in a unique and reliable position to be able to provide emotional, informational, cognitive and navigational support to patients dealing with cancer. We aimed to explore APs’ perspectives regarding the limiting and facilitating factors in terms of how they are integrated into the clinical oncology teams. Methods A qualitative study based on semi-structured interviews and focus groups was conducted with 20 APs at the beginning of their intervention (T1) and two years afterwards (T2). Limiting and facilitating factors of APs’ integration into clinical teams were analyzed in terms of governance, culture, resources and tools. Results The most significant limiting factors raised by APs to be integrated into clinical teams were: governance involvement, organizational boundaries, team members' availabilities, and confusion about the specific roles played by APs. Communication challenges were also raised, leading to inadequate promotion of the program to patients. The lack of time, space and compensation were also mentioned as limiting factors. Creating opportunities for team members to meet APs, building trust and teaching team members how APs’ activities are complementary to theirs were enhancing factors. Other facilitators include APs being involved in decision-making committees, being leaders in the PAROLE-Onco program promotion to patients and clinical team members and creating opportunities to communicate with team members to help enhance their work and provide feedback to improve patient services. Awareness of APs’ added value for the team and patients is also a key facilitator. Regarding tools, offering accompanying services by telephone allows both patients and APs to benefit from the flexibility they need. Conclusion Over time, APs were able to identify the best factors for successful implementation. Recommendations include APs and professionals working in co-construction on organization, leadership, resources, and status factors. This could help catalyze a change in culture within health establishments and allow people dealing with cancer to benefit from the experiential knowledge of other patients within their clinical team.

Publisher

Research Square Platform LLC

Reference37 articles.

1. Lacoursière A. Registre québécois du cancer: Le Québec est « dans le noir ». La Presse. https://www.lapresse.ca/actualites/sante/2022-06-14/registre-quebecois-du-cancer/le-quebec-est-dans-le-noir.php. Published June 14, 2022. Accessed September 12, 2022.

2. Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors;Patt D;JCO Clin Cancer Inform,2020

3. Rossy Cancer Network. P2-Outpatient Rating of Treatment Experience According to 6 Care Domains. http://www.mcgill.ca/rcr-rcn/scorecard/qualitydimension/ patient-experience/p2-outpatient-rating-treatment-experience.

4. The Patient Advisor, an Organizational Resource as a Lever for an Enhanced Oncology Patient Experience (parole-Onco): A Longitudinal Multiple Case Study Protocol;Pomey MP;BMC Health Serv Res,2021

5. Co-design for implementing patient participation in hospital services: A discussion paper;Castro EM;Patient Educ Couns,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3